|64.46|| -0.81 / -1.23%|
PAREXEL International Corp. is a biopharmaceutical services company, which provides clinical research, clinical logistics, medical communications, consulting, commercialization and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. The company operates its business through three segments: Clinical Research Services, PAREXEL Consulting & Medical Communication Services and Perceptive Informatics. The Clinical Research Services segment includes services such as clinical trials management and biostatistics, data management, clinical pharmacology, as well as related medical advisory, patient recruitment, clinical supply and drug logistics, pharmacovigilance, and investigator site services. The PAREXEL Consulting & Medical Communication Services segment provides a spectrum of market development, product development and targeted communications services in support of product launch. The Perceptive Informatics segment provides information technology solutions designed to improve client's product development processes. The segments portfolio of products and services includes ClinPhone RTSM, IMPACT CTMS, DataLabs EDC, web-based portals, systems integration, electronic patient reported outcomes and LIQUENT InSight Regulatory Information Management platform.PAREXEL International was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1982 and is headquartered in Waltham, MA.
|Josef H. von Rickenbach||Chairman & Chief Executive Officer|
|Mark A. Goldberg||President & Chief Operating Officer|
|Ingo Bank||Chief Financial Officer & Senior Vice President|
|Peter Steiger||Chief Scientific Officer & Vice President|
|Sy Pretorius||Chief Scientific Officer & Vice President|